Assembly Biosciences Inc $ 5.88 -0.06 (-1.01%)
Volume:
1,097,888
Avg Vol (1m):
909,404
Market Cap $:
194.17 Mil
Enterprise Value $:
-32,997,000.00
P/E (TTM):
0.00
P/B:
0.77
Financial Strength | 6/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 22.09 | ||
Equity-to-Asset | 0.88 | ||
Debt-to-Equity | 0.04 | ||
Debt-to-EBITDA | -0.2 | ||
Piotroski F-Score | 4 | ||
Altman Z-Score | 1.77 | ||
Beneish M-Score | 1.17 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -64.97 | ||
Net Margin % | -60.14 | ||
ROE % | -20.43 | ||
ROA % | -16.86 | ||
ROC (Joel Greenblatt) % | -402.09 | ||
3-Year EBITDA Growth Rate | -14.1 | ||
3-Year EPS without NRI Growth Rate | -13.1 |
ASMB
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 0.77 | ||
PS Ratio | 2.54 | ||
EV-to-EBIT | 0.61 | ||
EV-to-EBITDA | 0.62 | ||
EV-to-Revenue | -0.4 | ||
Current Ratio | 14.66 | ||
Quick Ratio | 14.66 | ||
Days Sales Outstanding | 15.82 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -23.6 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 0.91 | ||
Earnings Yield (Greenblatt) % | 163.93 |